First Time Loading...

Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 163.3 SEK 3.62% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

VITR Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VITR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VITR is 246.08 SEK with a low forecast of 222.2 SEK and a high forecast of 283.5 SEK.

Lowest
Price Target
222.2 SEK
36% Upside
Average
Price Target
246.08 SEK
51% Upside
Highest
Price Target
283.5 SEK
74% Upside
Vitrolife AB Competitors:
Price Targets
4974
Takara Bio Inc
101% Upside
NIOX
Niox Group PLC
16% Upside
6160
Beigene Ltd
50% Upside
IOVA
Iovance Biotherapeutics Inc
128% Upside
TNGX
Tango Therapeutics Inc
141% Upside
LGND
Ligand Pharmaceuticals Inc
69% Upside
QNCX
Quince Therapeutics Inc
183% Upside
ZURA
Zura Bio Ltd
279% Upside

Revenue
Forecast

Revenue Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 22%. The projected CAGR for the next 3 years is 9%.

22%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 15%.

16%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Vitrolife AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VITR's stock price target?
Price Target
246.08 SEK

According to Wall Street analysts, the average 1-year price target for VITR is 246.08 SEK with a low forecast of 222.2 SEK and a high forecast of 283.5 SEK.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 22%. The projected CAGR for the next 3 years is 9%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 15%.